| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |